There was a non-significant trend to greater TMRE loss in JAK2 V617F ET (n = 21) compared with JAK2-negative ET (n = 14), (thrombin, P = 0.07; thrombin + collagen, P = 0.07: Supplementary Fig. S3 online). This evidence concerns the gene JAK2 and essential thrombocythemia.